Search

everythinglearnresearchcommunity

for

Search:↓

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The letters discussed medical tools, costs, treatment efficacy, and patient care complexities.

Finasteride helps female-pattern hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Melatonin can help prevent and treat skin damage caused by gamma rays.

The AI model somewhat predicts lymph node status in melanoma patients using skin sample images.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hydroxychloroquine may help delay skin damage in lupus patients.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

A new method accurately measures nine specific hormones in human blood.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Afatinib often causes skin problems that need proactive management.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.